Impact of reduced exposure to calcineurin inhibitors on the development of de novo DSA: a cohort of non-immunized first kidney graft recipients between 2007 and 2014-Reference-Cited by-同舟云学术

Impact of reduced exposure to calcineurin inhibitors on the development of de novo DSA: a cohort of non-immunized first kidney graft recipients between 2007 and 2014

Published:2018-09-15 Issue:1 Volume:19 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Girerd S.,Schikowski J.,Girerd N.,Duarte K.,Busby H.,Gambier N.,Ladrière M.,Kessler M.,Frimat L.,Aarnink A.

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s12882-018-1014-2.pdf

Reference48 articles.

1. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clinical journal of the American Society of Nephrology : CJASN. 2009;4(2):481–508.

2. Gaston RS. Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm. Clinical journal of the American Society of Nephrology : CJASN. 2009;4(12):2029–34.

3. Matas AJ. Chronic progressive calcineurin nephrotoxicity: an overstated concept. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2011;11(4):687–92.

4. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2009;9(11):2520–31.

5. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation. 2010;90(1):68–74.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression;AM J TRANSPLANT;2023

2. A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression;American Journal of Transplantation;2023-12

3. Measurement of the Immunosuppressant Possession Ratio by Transplant Clinical Pharmacists Captures a Non-Adherence Associated With Antibody-Mediated Rejection;Transplant International;2023-11-28

4. Subtle Changes in Tacrolimus Levels Have an Impact on Early Donor-Specific Antibodies in Kidney Transplantation;Progress in Transplantation;2023-11-09

5. Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study;Vaccines;2022-10-09